FDA Drug Approval Decisions Expected in May 2024 - MPR - eMPR.com

Retrieved on: 2024-04-03 21:16:43

Tags for this article:

Orphan drugs

Cancer treatments

CAR T-cell therapy

Lisocabtagene maraleucel

Food and Drug Administration

Mantle cell lymphoma

Bruton's tyrosine kinase

PDUFA date

Lymphoma

Epidermolysis bullosa dystrophica

u.s. food and drug administration

Click the tags to see associated articles and topics

FDA Drug Approval Decisions Expected in May 2024 - MPR - eMPR.com. View article details on HISWAI: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-drug-approval-decisions-expected-in-may-2024/

Summary

The article details upcoming PDUFA dates for novel therapeutic agents being reviewed by the FDA, such as treatments for various cancers and genetic disorders, emphasizing the concept of 'healing' through advancements in orphan drugs, cancer treatments, and cell therapies.

Article found on: www.empr.com

View Original Article